EP0369496B1 - Mélange vaporisé thérapeutique et méthode pour sa préparation et application - Google Patents

Mélange vaporisé thérapeutique et méthode pour sa préparation et application Download PDF

Info

Publication number
EP0369496B1
EP0369496B1 EP89201564A EP89201564A EP0369496B1 EP 0369496 B1 EP0369496 B1 EP 0369496B1 EP 89201564 A EP89201564 A EP 89201564A EP 89201564 A EP89201564 A EP 89201564A EP 0369496 B1 EP0369496 B1 EP 0369496B1
Authority
EP
European Patent Office
Prior art keywords
mixture
enclosed space
gas particles
free
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP89201564A
Other languages
German (de)
English (en)
Other versions
EP0369496A2 (fr
EP0369496A3 (en
Inventor
Mohammed Essaidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to AT89201564T priority Critical patent/ATE98118T1/de
Publication of EP0369496A2 publication Critical patent/EP0369496A2/fr
Publication of EP0369496A3 publication Critical patent/EP0369496A3/en
Application granted granted Critical
Publication of EP0369496B1 publication Critical patent/EP0369496B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/06—Artificial hot-air or cold-air baths; Steam or gas baths or douches, e.g. sauna or Finnish baths
    • A61H2033/068—Steam baths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
    • A61H2033/143—Devices for gas baths with ozone, hydrogen, or the like with oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H33/00—Bathing devices for special therapeutic or hygienic purposes
    • A61H33/14—Devices for gas baths with ozone, hydrogen, or the like
    • A61H2033/148—Devices for gas baths with ozone, hydrogen, or the like with hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/04—Heartbeat characteristics, e.g. E.G.C., blood pressure modulation
    • A61H2230/06—Heartbeat rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2230/00—Measuring physical parameters of the user
    • A61H2230/30—Blood pressure

Definitions

  • This invention relates to a method for the preparation and application of a special vapourized mixture having therapeutical characteristics to be used in curing specific diseases in plant, human and animal cells by fully subjecting such affected cells to such vapourized mixture, which mixture is generated from a heated liquid and in which controllably a certain quantity of certain gas particles is added to said mixture.
  • vapourized mixture is generated from a heated liquid and in which controllably a certain quantity of certain free gas particles is added, a chemical reaction taking place and a new material, specified as "Aquatilis", being created under simultaneous generation of heat; these free hydrogen and free oxigen gas particles respectively, with which the vapour mixture is enriched thereafter being kept in a state wherein said supposedly diseased cells are entirely and intensively being surrounded by the "Aquatilis” mixture, and whereby during the treatment said mixture is kept in an enclosed space which it so voluminously occupies, and also keeping the mixture at a predetermined elevated temperature by generating more free gas particles and maintaining in said space a predetermined vapour pressure, thereby forcing "Aquatilis" to attack e.g.
  • the invention provides further for a novel method for the preparation of a special vapourized mixture having certain desirable therapeutic characteristics characterized in that the liquid used is normal water which is transferred by heat generation into saturated steam vapour and the generation of both free hydrogen and free oxygen gas particles being obtained by the electrolysis of water, whereafter the generated gases are added to and mixed up respectively with the steam vapour to a predetermined and fully controllable mixture ratio, a chemical reaction taking place and a new material, specified "Aquatilis" being created.
  • the novel method also provides for an absolutely novel therapeutic mixture, , called hereby "Aquatilis", which consists of a vapour mixture at an elevated temperature, a predetermined pressure and certain additives mixed up with said vapour mixture, which additives comprise at least different free gas particles, preferably but not exclusively free hydrogen and free oxygen gas particles, said vapour mixture being maintained in an enclosed space.
  • Aquatilis absolutely novel therapeutic mixture
  • said electrolysis is controllably carried out in a device containing normal water used during the application of the method and for effecting such control metal electrodes of equal or different material characteristics and of equal or different lengths and at mutual different distances, whereby any required concentration or ratio of the vapour content and gas particles content [Aquatilis] can be reatized by control and measuring device means.
  • the invention also provides for an enclosed space to contain the generated and enriched vapour mixture "Aquatilis", which space is provided thereto with entrance door means, container means for the liquid to be vapourized, heat generating means and a free gas particles distribution means.
  • an enclosed space may be shaped as a [sauna] cabin for treatment which is provided with general control and inspection means to carry out the novel method as described before.
  • the enclosed space or cabin according to the invention with a device in such a way that all relevant data about the liquid to be vapourized, data about the electrolysis and any other relevant data [e.g. relating to the person, the plant or the animal, subjected to the operation of the vaporised mixture] are collected and recorded by a central computing system unit which is located outside of the cabin.
  • these free gas particles which in itself are considered to be at least of a virulent character, thereby seem to cause the leucocytes of the blood to react in a very violent way against these intruding free gas particles.
  • an extra large quantity of such activated leucocytes rush upon the pretended or alleged intruders and consequently also rush upon other noxious nuclei which may be present in the blood as well and these attacked noxious nuclei may so be expelled from the body via the pores.
  • the human blood containing noxious nuclei is partly or totally treated outside the body, the treated blood again being brought in normal circulation afterwards.
  • An enclosed space 1 which may be a saunacabin of a type which is normally available in the trade, comprises an entrance door means 2 and a bank 3 to comfort a patient when under treatment.
  • the saunacabin 1 is provided also with medical indicator and checking means 4 which may e.g. comprise a blood pressure meter and a heart pulsation meter.
  • medical indicator and checking means 4 which may e.g. comprise a blood pressure meter and a heart pulsation meter.
  • These means 4 are interconnected by means of cables 5 contained in a conduct to a main control unit 6 from which the entire operation of the saunacabin 1 is watched.
  • Schematically shown only in the saunacabin 1 are located the means for carrying out the electrolysis of water.
  • a first container 7, a second container 8 and a third container 9 are provided for.
  • First container 7 is filled with water and it is closed by a non conducting lid 10 through which are carried two electrodes 11 and 12 respectively.
  • the power supply to the electrodes 11, 12, not shown here, is interconnected to the control unit 6 and by switching on the power supply, the water in the first container 7 is electrolytically decomposed into hydrogen and oxygen respectively.
  • Free hydrogen and oxygen gas particles generated by the electrolysis of the water are diffusing through the interconnecting tube 13 to the second container 8 to cause the deposition of impurities which may have been carried away with the free gas particles from the electrolytic process.
  • Another tube 14 is also interconnected between the second container 8 and the third container 9 .
  • This container 9 is filled with water to be vapourized to steam by means of heat generator means 15 which are also electrically interconnected (not shown here) to the main control unit 6.
  • heat generator means 15 which are also electrically interconnected (not shown here) to the main control unit 6.
  • the operator who operates the main control unit 6 may also actuate a fan 16 to let fresh air in the saunacabin 1 partly mix up with the "Aquatilis" mixture, depending on the individual necessity to apply for a gradual increase or decrease of the prompt effectiveness of the treatment to a person, an animal or a plant or the like.
  • a saunacabin 1 it has been discovered that it should at the inside be provided with stone tiles which are to be backed up by wall having very good isolating characteristics. It has also been found that obviously a much better efficiency can be obtained with the method by providing at least the vertical inner cabinwalls with reflecting mirror material in conjunction with special spot lights (not shown here) which apparently than also have a much greater positive effect on the duration of the treatment. For further comfort of the user of the saunacabin it has been found an advantage to install a commonly known water shower, the purpose of which need not be further described here.
  • the main control unit should preferably be controlled by means of a microprocessor which can be programmed for reliable saunacabin operation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Devices For Medical Bathing And Washing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Claims (10)

  1. Méthode pour la préparation d'un mélange vaporisé de manière que le mélange vaporisé obtienne des caractéristiques thérapeutiques afin d'être utilisé pour guérir des maladies spécifiques dans des cellules vivantes, le mélange étant produit par un liquide échauffé qui forme de la vapeur, des particules de gaz étant ajoutées, ayant la caractéristique que des particules d'hydrogène libres et des particules d'oxygène libres sont produites et utilisées pour enrichir le vapeur d'une façon controlée afin de produire un mélange vaporisé spécial lors de la production simultanée de chaleur, le mélange vaporisé étant conservé dans un espace fermé à une température et une pression de vapeur augmentées regularisées, prêt a combattre par exemple des groupes chimiques des soi-disants radicaux dont est supposé qu'ils se trouvent dans certains structures cellullaires malades.
  2. Méthode selon la revendication 1, les particules d'hydrogène et les particules d'oxygène étant obtenues par l'electrolyse d'eau.
  3. Méthode selon la revendication 1 ou la revendication 2, où de la lumière est produite dans l'espace fermé, la lumiére étant reflectée par des miroirs installé à l'intérieur de l'espace fermé.
  4. Mélange vaporisé, le mélange vaporisé étant conservé dans un espace fermé à une température augmentée et le mélange contenant de la vapeur, de l'oxygène, en plus grands quantités que normalement présent dans l'atmosphère, ainsi que de l'hydrogène, l'oxygène contenant des particules d'oxygène libres et le hydrogène contenant des particules d'hydrogène libres.
  5. Espace fermé, l'espace étant pourvu de moyens d'entrée, moyens de stockage pour le liquide à évaporer, des moyens produisant de chaleur ainsi qu'un appareil pour l'electrolyse de l'eau pour l'introduction d'oxygène et d'hydrogène dans l'espace fermé, l'appareil introduisant également des particules d'oxygène libres et des particules d'hydrogène libres dans l'espace fermé.
  6. Espace fermé selon la revendication 5, l'appareil étant pourvu des moyens general de contrôle et d'inspection afin d'éxécuter le méthode d'une des revendications 1 à 3.
  7. Espace fermé selon la revendication 5 ou la revendication 6, à l'extérieur de l'espace fermé étant installés les accessoires d'inspection medical accouplés à des moyens régulants et régistrants.
  8. Espace fermé selon une des revendications 5 à 7, toutes données rélévantes rélativement au liquide à evaporer, données rélativement à l'electrolyse et toutes autres données rélévantes rélativement au fonctionnement de la méthode selon une des revendications 1 à 3 par un système informatique central, placé hors de l'espace fermé, étant réunies et régistrées.
  9. Espace fermé selon une des revendications 5 à 8, l'espace fermé pourvu de moyens de lampe pour du faisceau lumineux et ayant des parois internes réalisés commes des miroirs, par lesquels la lumière, produite par les moyens de lampe est reflectée.
  10. Espace fermé selon une des revendications 5 à 9, l'espace fermé pourvu d'un douche d'eau.
EP89201564A 1988-05-27 1989-05-28 Mélange vaporisé thérapeutique et méthode pour sa préparation et application Expired - Lifetime EP0369496B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT89201564T ATE98118T1 (de) 1988-05-27 1989-05-28 Therapeutisches verdampftes gemisch und methode zu seiner herstellung und anwendung.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8801360A NL8801360A (nl) 1988-05-27 1988-05-27 Werkwijze voor het brengen van een mengsel in een voor therapeutische doeleinden geschikte vorm, inrichting voor het uitvoeren van de werkwijze en mengsel voor therapeutische doeleinden.
NL8801360 1988-05-27

Publications (3)

Publication Number Publication Date
EP0369496A2 EP0369496A2 (fr) 1990-05-23
EP0369496A3 EP0369496A3 (en) 1990-07-11
EP0369496B1 true EP0369496B1 (fr) 1993-12-08

Family

ID=19852361

Family Applications (2)

Application Number Title Priority Date Filing Date
EP89201564A Expired - Lifetime EP0369496B1 (fr) 1988-05-27 1989-05-28 Mélange vaporisé thérapeutique et méthode pour sa préparation et application
EP89907111A Pending EP0417201A1 (fr) 1988-05-27 1989-05-28 Procede de preparation et d'application d'un melange vaporise special, appele "aquatilis", ayant des proprietes therapeutiques, melange vaporise "aquatilis" et cabine permettant son application

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP89907111A Pending EP0417201A1 (fr) 1988-05-27 1989-05-28 Procede de preparation et d'application d'un melange vaporise special, appele "aquatilis", ayant des proprietes therapeutiques, melange vaporise "aquatilis" et cabine permettant son application

Country Status (10)

Country Link
EP (2) EP0369496B1 (fr)
JP (1) JPH03504566A (fr)
AT (1) ATE98118T1 (fr)
AU (1) AU639415B2 (fr)
BR (1) BR8907453A (fr)
DE (1) DE68911274T2 (fr)
ES (1) ES2046449T3 (fr)
NL (1) NL8801360A (fr)
OA (1) OA09331A (fr)
WO (1) WO1989011267A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9401289A (nl) * 1994-08-09 1996-03-01 Mohammed Essaidi Inrichting en werkwijze voor het bereiden van een op radicalen inwerkend therapeutisch elektrisch geladen dampmengsel.
EP2057990A4 (fr) * 2006-08-31 2010-08-04 Ohta Shigeo Agent améliorant le métabolisme lipidique contenant une molécule d'hydrogène
JP6163277B1 (ja) * 2017-04-12 2017-07-12 浩章 皆川 水素水蒸気スプレーポット
WO2018190322A1 (fr) * 2017-04-12 2018-10-18 隆 竹原 Outil d'aspiration de gaz électrolytique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB740945A (en) * 1953-10-13 1955-11-23 Eric Frederick St John Lyburn Improvements in or relating to therapeutic treatment cabinets
GB1352142A (en) * 1970-02-25 1974-05-08 Atesmo Ltd Apparatus for inducing hyperthermia
FR2376659A1 (fr) * 1977-01-06 1978-08-04 Somartec Sa Appareil pour le traitement dermatologique a l'aide d'un melange de vapeur d'eau et d'ozone

Also Published As

Publication number Publication date
DE68911274T2 (de) 1994-03-31
JPH03504566A (ja) 1991-10-09
ES2046449T3 (es) 1994-02-01
AU639415B2 (en) 1993-07-29
OA09331A (en) 1992-09-15
ATE98118T1 (de) 1993-12-15
AU3846489A (en) 1989-12-12
DE68911274D1 (de) 1994-01-20
EP0369496A2 (fr) 1990-05-23
EP0369496A3 (en) 1990-07-11
NL8801360A (nl) 1989-12-18
EP0417201A1 (fr) 1991-03-20
BR8907453A (pt) 1991-04-30
WO1989011267A1 (fr) 1989-11-30

Similar Documents

Publication Publication Date Title
Dyson et al. Effect of laser therapy on wound contraction and cellularity in mice
CN101005815A (zh) 通过喷射碳氟化合物进行高压经皮氧疗的方法
Howes et al. The effect of single and fractionated doses of X rays on the effective proportion of hypoxic cells in C3H mouse mammary tumours
EP0369496B1 (fr) Mélange vaporisé thérapeutique et méthode pour sa préparation et application
Habal Prevention of postoperative facial edema with steroids after facial surgery
CN111803304A (zh) 一种红外热疗舱
Boisnic Clinical and histopathological study
Hidderley et al. Effects of TENS applied to acupuncture points distal to a pain site
Strassberg et al. The effect on pain tolerance of social pressure within the laboratory setting
RU2306918C2 (ru) Мини-сауна
CN117281870A (zh) 一种中医用循龙灸方法
RU2238770C2 (ru) Физиотерапевтический комплекс
JPH0246897Y2 (fr)
CN111419950A (zh) 药香香性在人机体调养方面的应用
Smith et al. Acupuncture and ATP: how they may be related
Trovo et al. Radiotherapy (RT) enhanced by cis platinum (DDP) in stage III non small cell lung cancer (NSCLC)
Kang et al. A computer simulation of simultaneous heat and oxygen transport during heterogeneous three dimensional tumor hyperthermia
Sandström et al. Increased peripheral α‐adrenoceptor response in allergic asthmatics
Kagan Radiotherapy management of metastases
Gragtmans et al. A method for hyperthermic treatment of mouse skin
Radenovi et al. Relaxation induced by microwave resonance therapy: EEG correlates
Hunter et al. Karnofsky performance status (KPS) in unselected patients receiving external beam irradiation (XRT) for lung cancer-preliminary results of a pilot study
Belot Moderately Deep Radiotherapy: A Paper read at the Congress of the French Association for the Advancement of Science, held at Grenoble, July—August 1925
Bernstein Ultra Violet Rays in Modern Dermatology: Including the Evolution of Artificial Light Rays and Therapeutic Technique
Rhee et al. Improved deep heating with capacitive applications of 8 Mhz radiofrequency

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19900111

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): ES GR

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): ES GR

XX Miscellaneous (additional remarks)

Free format text: VERBUNDEN MIT 89907111.2/0417201 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 16.04.92.

17Q First examination report despatched

Effective date: 19921021

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19931208

REF Corresponds to:

Ref document number: 98118

Country of ref document: AT

Date of ref document: 19931215

Kind code of ref document: T

XX Miscellaneous (additional remarks)

Free format text: VERBUNDEN MIT 89907111.2/0417201 (EUROPAEISCHE ANMELDENUMMER/VEROEFFENTLICHUNGSNUMMER) DURCH ENTSCHEIDUNG VOM 16.04.92.

REF Corresponds to:

Ref document number: 68911274

Country of ref document: DE

Date of ref document: 19940120

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2046449

Country of ref document: ES

Kind code of ref document: T3

ITF It: translation for a ep patent filed

Owner name: PORTA CHECCACCI E BOTTI S.R.L.

ET Fr: translation filed
EPTA Lu: last paid annual fee
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EAL Se: european patent in force in sweden

Ref document number: 89201564.5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19960510

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19960514

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19960517

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19960520

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19960524

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 19960530

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19960531

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 19960601

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19960606

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19960711

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970528

Ref country code: GB

Effective date: 19970528

Ref country code: AT

Effective date: 19970528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19970529

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970529

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19970531

Ref country code: BE

Effective date: 19970531

BERE Be: lapsed

Owner name: ESSAIDI MOHAMMED

Effective date: 19970531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19971201

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19970528

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980130

EUG Se: european patent has lapsed

Ref document number: 89201564.5

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 19971201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980203

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 19990405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050528